8-K current report · filed Oct 26, 2026

RadNet, Inc. (RDNT) 8-K Current Report: October 26, 2026

Item EX-99.1Item 1.01Item 3.02Item 7.01RDNT overview

Short answer

RadNet, Inc. (RDNT) filed an 8-K current report with the SEC on October 26, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure). RadNet to acquire OnRad, a teleradiology provider, in a transaction expected to close in early 2027.

RadNet, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • RadNet to acquire OnRad, a teleradiology provider, in a transaction expected to close in early 2027
  • Consideration: $350 million cash, subject to adjustments, plus 5 million RadNet shares
  • Additional earn-out of up to $210 million tied to OnRad’s 2027 adjusted EBITDA target, payable in cash, stock or both
  • Closing depends on healthcare approvals, stockholder consent, CEO retention, physician ownership transfers and registration statement effectiveness
  • Seller lock-ups, non-compete and non-solicitation covenants may limit near-term share selling and protect acquired relationships

Item 3.02 · Unregistered Sales of Equity Securities

  • Item 3.02 contains no separate equity-sale details
  • Investors should review Item 1.01’s “Merger Agreement” section for the referenced transaction terms

Item 7.01 · Regulation FD Disclosure

  • RadNet announced entry into a merger agreement, signaling a potentially material change in ownership or corporate structure
  • Investor webcast and conference call scheduled for October 27, 2026 at 8:00 A.M. Eastern
  • Merger terms and transaction implications are detailed in Exhibit 99.1, the accompanying press release

Item EX-99.1 · Exhibit EX-99.1

  • Acquisition of ONRAD expands RadNet into hospital-based teleradiology and professional staffing, creating a third Radiology Professional Services segment
  • First-year contribution target: $190M-$200M revenue and $60M-$65M Adjusted EBITDA, implying a capital-light, high-margin growth platform
  • Consideration includes $350M cash, 5M RadNet shares, and up to $210M earnout tied to 2027 EBITDA, creating dilution and contingent payment exposure
  • ONRAD supports more than 225 hospitals across 26 states through more than 130 contracted radiologists, materially broadening RadNet’s customer reach
  • Closing expected in early 2027, subject to regulatory review and customary conditions; integration, leverage, retention and execution remain key risks

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other RadNet, Inc. 8-K filings

Get the next RDNT 8-K as it lands

Follow RDNT for push alerts, or ask the research agent what this filing means.